Full-Time

Senior Design Assurance Quality Engineer

Posted on 7/17/2025

Neptune Medical

Neptune Medical

1-10 employees

At-home fertility diagnostics and non-invasive device

Compensation Overview

$140k - $175k/yr

+ Equity

Burlingame, CA, USA

In Person

Company is located in Burlingame, CA; no explicit hybrid/remote option mentioned; role expects working at startup in California.

Category
QA & Testing (1)
Required Skills
Minitab
Risk Management
Requirements
  • B.S. or M.S. in an Engineering discipline or related field of study
  • Minimum of 5 years of experience in the medical device industry; Class II or III electro-mechanical medical devices preferred
  • Hands-on experience with design controls, risk management practices, and regulatory submissions (e.g., FDA QSRs)
  • Proficiency in standards such as ISO 13485, ISO 14971, IEC 60601, IEC62304
  • Advanced statistical methods knowledge (e.g., DOE, ANOVA) using tools like Minitab
  • Working knowledge of verification and validation requirements for a regulated product
  • Working knowledge of requirements analysis, including development of testable and measurable specifications
  • Ability to effectively work on project teams, including taking leadership role on critical tasks to assure appropriate and timely completion/resolution
  • Ability to manage multiple projects simultaneously under tight deadlines
  • Willingness to work in a startup environment and adapt to changing needs and priorities
  • Must be able to work independently and as a member of a cross-functional team, to multi-task and do what it takes to meet high expectations and tight deadlines
  • Excellent verbal and written communications skills including presentation of technical content
  • Eagerness to learn new things
Responsibilities
  • Develop and maintain Design History Files (DHF) and ensure compliance with regulatory requirements
  • Support the creation of technical documentation, including design specifications, verification/validation protocols, and risk management files
  • Actively participate in the Design Change process to ensure the proposed changes to the products are systemically and thoroughly analyzed and assessed
  • Lead risk analysis activities such as Hazard Analysis, Design Failure Modes and Effects Analysis (DFMEA) and Process FMEA
  • Leads the development of and coordinates the execution and documentation of Design Validation and Verification activities
  • Plan, execute, and document design verification and validation activities, including software validation
  • Coordinate with third-party test houses for compliance testing (e.g., EMC, EMI) to meet regulatory standards
  • Support biocompatibility and sterilization qualifications
  • Supports product Post Market activities such assessment of risk based on post market signals, field assessments, and post market surveillance plans and reports
  • Applies sound, systematic problem-solving methodologies in identifying, prioritizing, communicating, and resolving quality issues
  • Demonstrate good working knowledge and application of validation and statistical techniques to comply with associated regulatory requirements and internal standards
  • Provide support for internal audits and regulatory inspections
Desired Qualifications
  • None

Neptune Medical develops devices and tests to address male infertility. Its two main products are Pro-Test, an at-home diagnostic kit that lets individuals test fertility parameters from home, and Neptune, a non-invasive device designed to improve sperm quality. Pro-Test provides a convenient way to assess fertility without clinic visits, while Neptune uses a proprietary, non-invasive method to enhance key sperm metrics and is intended for home use alongside clinical fertility treatment. The company serves both clinics (B2B) and individual consumers (B2C) and markets its products to help diagnose and treat male infertility, a factor in about half of all infertility cases. Neptune Medical differentiates itself by offering integrated, consumer-accessible diagnostics and treatment tools, backed by grant funding and participation in precision medicine programs, aiming to make diagnosis and treatment more private, accessible, and effective.

Company Size

1-10

Company Stage

Series D

Total Funding

$97M

Headquarters

Burlingame, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Varicocele embolization boosts sperm parameters, complementing Neptune's enhancement device.
  • E-cigarette harm awareness drives Pro-Test demand for lifestyle-impacted diagnostics.
  • Innovate UK and Horizon 2020 grants validate clinical innovation for market entry.

What critics are saying

  • Varicocele embolization by University Radiology eliminates Neptune device need in 12-24 months.
  • RSC New Jersey clinics integrate evaluations, cutting Pro-Test demand in 6-18 months.
  • Clomiphene citrate adoption by urologists cannibalizes device market in 12-24 months.

What makes Neptune Medical unique

  • Pro-Test delivers at-home male fertility diagnostics for convenient sperm analysis.
  • Neptune device non-invasively enhances sperm quality via patented home-use technology.
  • Targets male infertility gap, serving B2B clinics and B2C consumers since 2018.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Company Equity

Company News

The Robot Report
Oct 4th, 2024
Robotics Investments Near $1B In August

Listen to this articleSwiss-Mile raised $22M in August 2024 for its wheeled quadruped. Fifty producers of robots and robotics enabling technologies received funding in August 2024, pulling in a total of approximately $1 billion. This figure is on par with the $1.2 billion average The Robot Report has tracked each of the previous 12 months. Investment targeted to robotics companies for the first eight months of 2024 equals about $10.86 billion. You can follow The Robot Report‘s investment section here. The largest investments in August were secured by developers of autonomous driving technologies

Business Wire
Aug 17th, 2024
Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Neptune Medical announces $97 million in Series D financing, along with the spinout of its Jupiter Endovascular subsidiary.

INACTIVE